| Dr Gene Neytman, DO | |
|
1674 Meridian Ave, Suite 201, Miami Beach, FL 33139-2801 | |
| (305) 760-8756 | |
| (305) 760-8759 |
| Full Name | Dr Gene Neytman |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 24 Years |
| Location | 1674 Meridian Ave, Miami Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003845801 | NPI | - | NPPES |
| 277465800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | OS8861 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Medical Center | Miami beach, FL | Hospital |
| Entity Name | Gene Neytman Do Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780909499 PECOS PAC ID: 2567595952 Enrollment ID: O20100805000677 |
News Archive
In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."
A new, specially coated iron oxide nanoparticle developed by a team at MIT and elsewhere could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging procedures.
The implantable pacemaker, a medical marvel that has extended millions of lives since its invention nearly 60 years ago, is getting a 21st century makeover.
In the current issue of Cardiovascular Innovations and Applications (Volume 2, Number 4, 2018, pp 439-446(8); DOI: https://doi.org/10.15212/CVIA.2017.0027, researchers Yee-Ping Sun and Patrick T. O'Gara, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA present a case study of management of rheumatic mitral regurgitation in a woman contemplating pregnancy.
Phase III trial findings suggest that carrying out stereotactic radiosurgery before chemotherapy does not improve overall survival for non-small-cell lung cancer patients with asymptomatic brain metastases compared with chemotherapy alone.
› Verified 9 days ago
| Entity Name | Nano Health Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952727356 PECOS PAC ID: 3678899903 Enrollment ID: O20150304002103 |
News Archive
In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."
A new, specially coated iron oxide nanoparticle developed by a team at MIT and elsewhere could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging procedures.
The implantable pacemaker, a medical marvel that has extended millions of lives since its invention nearly 60 years ago, is getting a 21st century makeover.
In the current issue of Cardiovascular Innovations and Applications (Volume 2, Number 4, 2018, pp 439-446(8); DOI: https://doi.org/10.15212/CVIA.2017.0027, researchers Yee-Ping Sun and Patrick T. O'Gara, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA present a case study of management of rheumatic mitral regurgitation in a woman contemplating pregnancy.
Phase III trial findings suggest that carrying out stereotactic radiosurgery before chemotherapy does not improve overall survival for non-small-cell lung cancer patients with asymptomatic brain metastases compared with chemotherapy alone.
› Verified 9 days ago
| Entity Name | Pro-echo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912936105 PECOS PAC ID: 1355323452 Enrollment ID: O20170425003131 |
News Archive
In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."
A new, specially coated iron oxide nanoparticle developed by a team at MIT and elsewhere could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging procedures.
The implantable pacemaker, a medical marvel that has extended millions of lives since its invention nearly 60 years ago, is getting a 21st century makeover.
In the current issue of Cardiovascular Innovations and Applications (Volume 2, Number 4, 2018, pp 439-446(8); DOI: https://doi.org/10.15212/CVIA.2017.0027, researchers Yee-Ping Sun and Patrick T. O'Gara, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA present a case study of management of rheumatic mitral regurgitation in a woman contemplating pregnancy.
Phase III trial findings suggest that carrying out stereotactic radiosurgery before chemotherapy does not improve overall survival for non-small-cell lung cancer patients with asymptomatic brain metastases compared with chemotherapy alone.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gene Neytman, DO 1674 Meridian Ave, Suite 201, Miami Beach, FL 33139-2801 Ph: (305) 760-8756 | Dr Gene Neytman, DO 1674 Meridian Ave, Suite 201, Miami Beach, FL 33139-2801 Ph: (305) 760-8756 |
News Archive
In the latest installment of the PLOS "Speaking of Medicine" blog's Q&A series, Pamela Collins, director of the Office for Research on Disparities and Global Mental Health at the National Institute of Mental Health and "the corresponding author of a series of Policy Forum articles in PLOS Medicine that provides a global perspective on integrating mental health," answers questions "about some of the topics discussed in the new series, which will be published in PLOS Medicine weekly for the next five weeks, starting with the publication [on Tuesday] of a Policy Forum article discussing integration in research, policy, and practice."
A new, specially coated iron oxide nanoparticle developed by a team at MIT and elsewhere could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging procedures.
The implantable pacemaker, a medical marvel that has extended millions of lives since its invention nearly 60 years ago, is getting a 21st century makeover.
In the current issue of Cardiovascular Innovations and Applications (Volume 2, Number 4, 2018, pp 439-446(8); DOI: https://doi.org/10.15212/CVIA.2017.0027, researchers Yee-Ping Sun and Patrick T. O'Gara, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA present a case study of management of rheumatic mitral regurgitation in a woman contemplating pregnancy.
Phase III trial findings suggest that carrying out stereotactic radiosurgery before chemotherapy does not improve overall survival for non-small-cell lung cancer patients with asymptomatic brain metastases compared with chemotherapy alone.
› Verified 9 days ago
Dr. Seth Gottlieb, M.D.,F.C.C.P Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4302 Alton Rd Ste 940, Miami Beach, FL 33140 Phone: 305-674-2055 Fax: 305-674-2075 | |
Rodolfo Dumenigo, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1200 Alton Rd, Miami Beach, FL 33139 Phone: 305-534-0076 | |
Dr. Carlos E Gomez, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 71 Street, Suite 620, Miami Beach, FL 33141 Phone: 305-866-9951 Fax: 305-614-3352 | |
Carlos Arturo Villalba, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 4308 Alton Rd, 860, Miami Beach, FL 33140 Phone: 305-604-2888 Fax: 305-604-2887 | |
Berta Pita, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4300 Alton Rd, Miami Beach, FL 33140 Phone: 305-674-2121 | |
Dr. Joseph C Chan, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 4300 Alton Rd, Greene Pavilion, Miami Beach, FL 33140 Phone: 305-673-5490 Fax: 305-674-2765 |